Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.

By J. D. de Lemos, M. Blazing, S. Wiviott, E. Lewis, K. Fox, Harvey D. White, J. Rouleau, T. Pedersen, L. Gardner, R. Mukherjee and 6 more. Journal of the American Medical Association (JAMA), 2004

1,397 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Radiology, Nuclear Medicine and Imaging, Surgery

View Paper: https://www.semanticscholar.org/paper/2b51aab50d025c4dff23975000c5e8fe8309875a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

1. I. Graham
2. Diederick E. Grobbee
3. B. Mihaylova
4. Peter Jüni

In Radiology, Nuclear Medicine and Imaging

1. Marja-Riitta Taskinen
2. J. Liao
3. I. Graham
4. Ulrich Laufs

In Surgery

1. I. Graham
2. Marja-Riitta Taskinen
3. J. Liao
4. Alberico L. Catapano
5. Ulrich Laufs

Citations in the corpus

• Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study (2005, background): “Indeed, the increased risk of muscular side effects with high-dosage statin therapy was recently illustrated by the Aggrastat to Zocor (A to Z) trial [20].”
• Pleiotropic Effects of Statins on the Cardiovascular System (2017, background): “From month 4 onward, there was a reduction of CRP in the high-intensity simvastatin group, and the trend to benefit was stronger after 4 months then earlier.(51) Both groups had relatively low CRP (2.”